Difficulty: Medium
Average Score: 67%
Practice
Granulocytic sarcoma masses are commonly seen in which type of the following malignancies?
Correct answer
D
Rationale
Granulocytic sarcoma, also known as chloroma, is a rare extramedullary tumor composed of immature granulocytic cells. It is commonly associated with acute myeloid leukemia (AML). The correct answer is D) AML because granulocytic sarcoma is a potential presenting feature of AML, often occurring before the diagnosis of leukemia is established.
Option A) neuroblastoma is incorrect as it is a tumor of neuroblasts arising in sympathetic ganglia and the adrenal medulla, not associated with granulocytic sarcoma. Option B) rhabdomyosarcoma is a soft tissue tumor that arises from skeletal muscle progenitor cells, not related to granulocytic sarcoma. Option C) soft tissue sarcoma encompasses various types of tumors arising from soft tissues, but it is not specifically associated with granulocytic sarcoma.
In an educational context, understanding the association of granulocytic sarcoma with AML is important for healthcare providers, especially in pediatrics. Recognizing this relationship can aid in early diagnosis and appropriate management of AML, improving patient outcomes. This question also highlights the need for clinicians to consider rare manifestations of malignancies in pediatric patients, emphasizing the importance of a comprehensive approach to diagnosis and treatment.
Option A) neuroblastoma is incorrect as it is a tumor of neuroblasts arising in sympathetic ganglia and the adrenal medulla, not associated with granulocytic sarcoma. Option B) rhabdomyosarcoma is a soft tissue tumor that arises from skeletal muscle progenitor cells, not related to granulocytic sarcoma. Option C) soft tissue sarcoma encompasses various types of tumors arising from soft tissues, but it is not specifically associated with granulocytic sarcoma.
In an educational context, understanding the association of granulocytic sarcoma with AML is important for healthcare providers, especially in pediatrics. Recognizing this relationship can aid in early diagnosis and appropriate management of AML, improving patient outcomes. This question also highlights the need for clinicians to consider rare manifestations of malignancies in pediatric patients, emphasizing the importance of a comprehensive approach to diagnosis and treatment.